Diabetic retinopathy in the greater adult.
Abstract
A cross-sectional descriptive observational study was carried in the Diabetic Center of Ciego de Avila from June 2009 to June 2010, with the aim to determine the prevalence of diabetic retinopathy in elderly patients. The sample was integrated by 113 diabetic patients types I and II with diabetic retinopathy. An ophthalmological clinical history designed by the investigator to all patients was carried out to them. Diabetic retinopathy was pronounced with more frequency in patients between 60 and 69 years that 75.2% represented. 62.8% of Feminine sex predominated, and according to time of evolution of the disease those of more than 10 years prevailed, with 66 patients that constituted a 58.4% of the sample. The DM type II predominated with an 85.8%. Associate diseases were hypertension in 57.5%, primary open-angle glaucoma (27.4%) and high cholesterol (13.3%). No proliferative diabetic retinopathy appeared in 88 patients (77.9%).Downloads
Author Biographies
Elizabeth Morffi González
Yohany Díaz Díaz
Vicente Fernández Pérez
Karinne Peña Hernández
Carlos Alberto Pérez Padilla
References
Jácome Roca A. Diabetes al día. Hispanos diabéticos en América Latina y del norte [Internet]. 2012 [citado 12 Oct 2012] [aprox. 2 pantallas]. Disponible en: http://encolombia.com/medicina/sociedadescien/diabetes1201hispan osdiab.htm
Yau JW. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64.
Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, editores. Diabetes mellitus y trastornos del metabolismo de los hidratos de carbono en: El Manual Merck de diagnóstico y tratamiento 11va ed. Madrid: Elseiver; 2006. p. 1390-94.
Socarrás Suárez M, Bolet Astoviza M, Licea Puig M. Diabetes mellitus: tratamiento dietético. Rev Cubana Invest Bioméd [Internet]. 2002 [citado 12 Oct 2012]; 21(2): [aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-03002002000200007&script= sci_arttext&tlng=en
Gónzalez Gómez SR. Diabetes mellitus. Rev Cubana Med [Internet]. 2005 [citado 12 Oct 2012]; 44(5-6): [aprox. 5 p.]. Disponible en: http:// scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232005000500008&lng=es&nrm=iso&tlng=es
Osorio Illas L, Paisán Rizo WM, Hitchman Barada D. Factores de riesgo asociados a la retinopatía diabética en pacientes diabéticos tipo II. Rev Cubana Med Gen Integr [Internet]. 2006 [citado 12 Oct 2012]; 22(1): [aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252006000100016&script=sci_arttext&tlng=en
Cunha Vaz J. Lowering the risk of visual impairment and blindness. Diabet Med. 1998; 15 Suppl 4:S47-50.
Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings. Diabetes Res Clin Pract. 2006; 74(3):301-8.
Maylahn C, Gohdes D, Balamurugan A, Larsen B. Age-related eye diseases: an emerging challenge for public health professionals. Prev Chronic Dis. 2005; 2(3): A17.
Hietala K, Harjutsalo V, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 2010; 33(6):1315-9.
Crespo Valdés N, Padilla González JC, González Fernández R, Crespo Mojena N, Rodríguez Casales M, Hernández Beguiristain JD. Prevalencia de la retinopatía diabética en pacientes del nivel primario de salud. Rev Cubana Med Gen Integr [Internet]. 2004 [citado 12 Oct 2012]; 20(2): [aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php? pid=S0864-21252004000200001&script= sci_arttext
Hernández Pérez A, Tirado Martínez O, Rivas Canino MC, Licea Puig M, Maciquez Rodríguez JE. Factores de riesgo en el desarrollo de la retinopatía diabética. Rev Cubana Oftalmol [Internet]. 2011 [citado 12 Oct 2012]; 24(1):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.Php? script=sci_arttext&pid=S086421762011000100009&lng=es&nrm=iso&tlng=es
Abbate R, Mannucci E, Cioni G, Fatini C, Marcucci R. Diabetes and sex: from pathophysiology to personalized medicine. Intern Emerg Med. 2012; 7(Suppl 3):215-9.
Harjutsalo V, Maric C, Forsblom C, Thorn L, Wadén J, Groop PH; FinnDiane Study Group. Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia. 2011; 54(8):1992-9.
Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009; 116(3):461-7.
Sigler Villanueva A, Jímenez Barredo J, Gómez Carro R, Rodríguez Sánchez LA, Posada Fernández P, Maqueira Roque JM, et al. Análisis de algunas variables clínicas en relación con la retinopatía diabética. Rev Cubana Oftalmol. 1996; 9(2):122-127.
Li Y, Fan AZ, Balluz LS. Visual impairment and age-related eye diseases in Florida: findings from 2006 Behavioral Risk Factors Surveillance System (BRFSS) in nine states. Risk Manag Healthc Policy. 2009; 2:65-71. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270904/
Williams ME. The goal of blood pressure control for prevention of early diabetic microvascular complications. Curr Diabet Rep [Internet]. 2011 [citado 12 Oct 2012]; 11(4): 323-9. Disponible en: http://www.springerlink.com/index/X3674455857L6017.pdf
Anan F, Masaki T, Ito Y, Eto T, Umeno Y, Eshima N, et al. Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. Metabolism [Internet]. 2010 [citado 12 Oct 2012]; 59(3):314-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S0026049509002467
Damkondwar DR, Raman R, Suganeswari G, Kulothungan V, Sharma T. Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian J Ophthalmol [Internet]. 2012 [citado 12 Oct 2012]; 60(1):45-8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263245/
Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
